Skip to main content

Table 2 Laboratory characteristics of severe COVID-19

From: Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19)

Variables

Mean ± SD, Median (IQR), or N (%)

White blood count, × 109/L

5.8 (4.3–8.5)

Neutrophil count, × 109/L

3.7 (2.4–7.1)

Lymphocyte count, × 109/L

1.1 (0.7–1.6)

Platelet count, × 109/L

211.5 (164.0–301.0)

Hemoglobin, g/L

119.2 ± 20.2

Prothrombin time, s

13.9 (13.4–14.4)

Activated partial thromboplastin time, s

39.1 (35.7–43.5)

Fibrinogen, g/L

4.76 ± 1.55

D-dimer, mg/L

1.1 (0.4–3.5)

Alanine aminotransferase, U/L

19.0 (12.0–41.0)

Creatinine, μmol/L

67.0 (57.5–86.5)

Procalcitonin, ng/ml

0.07 (0.03–0.10)

Interleukin-6, pg/ml

7.67 (3.01–23.51)

Ferritin, ng/ml

559.3 (304.7–1214.6)

hsCRP, mg/ml

11.6 (2.6–47.1)

Cardiac damage

25 (25.0)

hsTnI, pg/ml

3.5 (1.9–11.2)

 Increased (> 34.2)

9 (9.0)

NTproBNP, pg/ml

133.5 (42.3–369.5)

 Increased#

22 (22.0)

Influenza A antibody

5 (5.0)

  1. COVID-19 = coronavirus disease 2019; hsCRP = hypersensitive C-reactive protein; hsTnI = hypersensitive troponin I; NTproBNP = N-terminal-pro brain natriuretic peptide. #Increased NTproBNP was above 450 pg/ml at the age < 50, above 900 pg/ml at the age < 75, or above 1800 pg/ml at the age ≥ 75